Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Forge Resources Intercepts 105 G/T Au in the Payoff Zone at Alotta Project, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CardioComm Solutions Inc V.EKG

Alternate Symbol(s):  EKGGF

Healthcare Medical Devices
CardioComm Solutions, Inc. develops advanced software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company’s proprietary device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for recording, transmission, viewing, analyzing, reporting and storage of ECGs. The Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud-based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. It also holds Class II medical device clearances for the manufacture, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.


TSXV:EKG - Post by User

CardioComm Solutions Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
  • WillwinbigX
Post by Willwinbigon Apr 04, 2022 8:11pm
386 Views
Post# 34575097

An update soon??

An update soon??As per this news release of Nov 4, 2021 we should expect an update soon, may be ? hopefully :)
It would be nice to see some progress report.

CardioComm Solutions to Develop Full Body, Multiple-Biosignal Remote Patient Monitoring Solutions

https://finance.yahoo.com/news/cardiocomm-solutions-develop-full-body-195000635.html

Extract: 
The first phase, which will support ECG, blood pressure, temperature and P02 monitoring, is expected to be completed in Q1 2022. The Company wishes to confirm that partial support for the first phase of this undertaking is provided through a grant from the NRC Industrial Research Assistance Program (NRC-IRAP).


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities